For instance, in several cancers, Beclin-1 has been shown to suppress tumor growth in some malignancies, such as lung cancer, synovial sarcoma, and laryngeal squamous carcinoma,17,18,19 while promoting tumor progression in others, such as colon cancer and ER-positive breast cancer.20 This evidence concerns the gene BECN1 and synovial sarcoma.